Dr. Stephen Rosenberg

About Stephen Rosenberg

Accolades

• 

  Pleural and Lung Cancer

• 

  Excellence in Research

• 

  10+ Years of Experience

• 

  Works for Specialty Center

• 

  Board Certified in Radiation Oncology

Dr. Stephen Rosenberg specializes in treating lung cancer, mesothelioma, pancoast tumors and thymoma.

He personalizes his radiation therapy with a novel approach that often decreases side effects and improves control of local tumors.

Rosenberg combines radiation with immunomodulatory drugs and targeted therapies. He has spent considerable time researching the effectiveness of MRI-guided radiation therapy.

As part of his research efforts, he has studied the utilization of radiomics and genomics. His work is part of the Future of Radiation Therapy program at Moffitt, which is designed to increase the effectiveness of personalized treatment.

Published Author on Cancer Treatment

Rosenberg authored the book “Cancer What You Need to Know: Overcome the 10 Common Mistakes Patients Make.”

One of his goals with the book was to take issues surrounding the diagnosis and treatment of cancer — particularly the medical terms and concepts — and make them easier to understand.

The book stemmed from a previous study he did that examined the websites of National Cancer Institute-Designated Cancer Centers and demonstrated their lack of readability by the general public.

“What we found looking at the information was that it was at a level that most people could not understand,” Rosenberg said. “There was a big disconnect between what we should be presenting to patients, what they can understand, versus what we’re actually writing for patients.”

Part of a Multidisciplinary Team at Moffitt

Rosenberg graduated from the Rutgers Robert Wood Johnson Medical School. He completed his residency at the University of Wisconsin.

He did a medical internship at Memorial Sloan Kettering Cancer Center in New York, where he was named Intern of the Year.

Rosenberg joined the Mesothelioma Research and Treatment Center at Moffitt in 2018 after four years at the University of Wisconsin.

At Moffitt, he works with a multidisciplinary team of mesothelioma specialists, all with experience in treating this rare cancer typically caused by exposure to asbestos.

Patients at Moffitt often are eligible for clinical trials, where advances in mesothelioma treatment are being made.

Recent clinical trials have studied immunotherapy, gene therapy and targeted therapies, along with minimally invasive and robotic surgeries.

See More Top Mesothelioma Doctors